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Abstract
Imaging mass spectrometry (IMS) is an emerging technology, pioneered by Prof. Richard Caprioli’s group
starting more than a decade ago. In this study we have demonstrated the simplicity of initial technological set up
for IMS experiments with commercially available automated matrix deposition, MALDI-TOF mass spectrom-
etry instrumentation and data handling software for image generation. We have applied two different concepts of
automated matrix deposition on Murine brain sections and discussed their different features and capabilities in
IMS.
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Introduction
Proteomics has seen the development of evermore com-
plex and labour intensive methodologies and technologies,
with increased qualitative and quantitative analytical power
(Schmidt, Kellermann et al. 2005; Vanrobaeys, Van Coster
et al. 2005; Mitulovic and Mechtler 2006). As the work-
horses of proteomics, two-dimensional gels and high per-
formance liquid chromatography (HPLC) allow exquisite
protein/peptide separation and thus in depth proteome analysis
in high throughput formats (Vanrobaeys, Van Coster et al.
2005). Such classical proteomics, however, require protein/
peptide sample solubilisation and treatment (E.g. precipita-
tion, purification, labelling) prior to separation and down-
stream analysis by mass spectrometry [MS] (Schmidt,
Kellermann et al. 2005; Vanrobaeys, Van Coster et al. 2005).
Furthermore, studies seeking diagnostic markers typically
use bodily fluids as the basis for investigation, raising the
possibility of multiple high abundance species complicating
analysis. Spatial information is also lost when solubilisation
and protein separation are applied to tissue samples. In this
light, it is not surprising that almost a decade ago direct MS
analysis on tissue sections was pioneered by Caprioli et al
(Caprioli, Farmer etal. 1997; Chaurand, Norris et al. 2006).
MS is now regularly being applied to in situ tissue analysis
(Schwartz, Reyzer et al. 2003; Seeley, Oppenheimer et al.
2008; Stauber, Lemaire etal. 2008). Typically, tissue sec-
tions are washed in alcohol, dried and either a homogeneous
layer or droplet array of matrix is applied (Schwartz, Reyzer
et al. 2003). Direct MS desorption from the matrix co-
crystallised tissue surface is then performed: predominantly
with Matrix Assisted Laser Desorption/Ionisation (MALDI)
sources (Seeley, Oppenheimer etal. 2008; Stauber, Lemaire
et al. 2008). Prior knowledge of tissue composition is not
necessary, hundreds if not thousands of masses can be mea-
sured rapidly and spatial distribution information is main-
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tained (Chaurand, Norris et al. 2006). To date, IMS has
been applied in several biological systems including rodent
(Schwartz, Reyzer et al. 2003; Baluya, Garrett et al. 2007;
Groseclose, Andersson et al. 2007) and crustacean brain
(Dekeyser, Kutz-Naber et al. 2007), rodent spinal cord
(Monroe, Annangudi et al. 2008), liver (Seeley, Oppenheimer
et al. 2008), testes, kidney (Herring, Oppenheimer et al.
2007) and skin (Bunch, Clench et al. 2004). Due to its rela-
tive infancy, IMS still requires optimisation of many of its
component protocols, including those for section washing,
effective and reproducible matrix deposition and process-
ing the large volumes of data generated. Thus, although great
progress has been made by several groups no standard IMS
methodology has been defined.
With this is mind it was the objective to develop an IMS
platform in our laboratory, focused on the imaging aspects
of an IMS experiment prior to profiling applications for sta-
tistical model generation and potential diagnostic applica-
tions (Lemaire, Menguellet et al. 2007; Stauber, Lemaire et
al. 2008). One of the most challenging aspects of IMS is
the reproducible application of matrix on tissue sections.
Three different commercial systems are currently available
for automated matrix deposition, including the ImagePrep
station (Bruker Daltonics), the CHIP-1000 printer (Shimadzu
Biotechnology) and the Portrait 630 printer (Labcyte). The
ImagePrep station uses vibrational vaporization to generate
a matrix aerosol, which gently settles onto tissue samples.
The CHIP-1000 and Portrait 630 are both picolitre range
droplet printers capable of generating discrete matrix ar-
rays on tissue sections. However, while the CHIP-1000 uses
piezoelectric technology to forcefully eject droplets from a
printer head, the Portrait 630 uses acoustic ejection of drop-
lets from a liquid surface. We were able to successfully
apply IMS to murine brain sections using both the CHIP-
1000 and the ImagePrep in conjunction with a MALDI-
TOF-MS instrument and image generation software. Un-
der these conditions a comparison between the two instru-
ments using similar sagittal murine brain sections is pro-
vided in this communication. Continued optimisation of key
methodological steps is still needed, including maintenance
of tissue integrity, section washes, matrix solvent composi-
tion and matrix deposition strategy. However, we have shown
that the technology can be implemented with commercially
available instrumentation in a relatively short timeframe. The
potential of this technology for future application in biomarker
discovery and diagnostics looks extremely promising.
Experimental Methods
Experimental Tissues and Solvents
 Murine brain tissue was scavenged from on going ex-
periments in the Chemokine laboratory at the University of
Adelaide. All source experiments had full ethics approval
from the University of Adelaide Ethics Committee. Solvents,
acetonitrile (ACN) and methanol (MeOH) were HPLC
grade (Merck, Damstadt, Germany). Ethanol (EtOH) and
isopropanol (IPA) were analytical grade or higher (Merck).
Trifluoroacetic acid (TFA) was purchased from Applied
Biosystems (Foster City, CA). Sinapinic acid (SA) and pep-
tide/protein standards (ClinProT standards, Bruker
Daltonics) used to calibrate the Ultra Flex III MALDI-TOF/
TOF mass spectrometer were purchased from Bruker
Daltonics (Bremen, Germany).
Sample Preparation
Mice were sacrificed by carbon dioxide asphyxiation and
tissues of interest were excised within ten minutes of sacri-
fice. Tissues were slow frozen in foil floated on liquid nitro-
gen (N2(l)) and transferred on dry ice to a -80°C freezer.
Tissues were equilibrated to -20°C, followed by sectioning
at -20°C (brain) or -18°C (other organs). Tissue was sec-
tioned at a thickness of 10 ìm with 35 x 80 mm blades in a
Shandon cryotome (Thermo Electron, Pittsburgh, PA). Sec-
tions were mounted onto pre-chilled Indium Tin Oxide (ITO)
slides (Bruker Daltonics) using heat from the operators hand
applied underneath the slide. Mounted sections were desic-
cated for 45 minutes prior to washes for 60 seconds in 100ml
of 70% EtOH or IPA followed by 60 seconds submerged in
100ml of 100% EtOH or IPA. Following washes sections
were desiccated for 15 minutes. Use of IPA in washes was
an alteration to protocols due to published data (Seeley,
Oppenheimer et al. 2008).
Matrix Deposition – CHIP-1000
The CHIP-1000 piezo electric printer (Shimadzu Biotech-
nology, Kyoto, Japan) was operated as per manufacturer’s
instructions to deposit 250 ìm centre to centre arrays of SA
matrix directly onto tissue sections. Dwell voltage and dwell
time were modulated as necessary to maintain the quality
of droplets for deposition. Prior to printing the piezo printer
head was flushed with several volumes of 50% IPA. Fol-
lowing printing the piezo printer head was flushed with 200
ìl of 50% IPA and the outside rinsed with 50% IPA (3x),
100% MeOH (3x) and 100% ultra pure water (Resistivity
18.2 MW-cm, TOC < 1ppb) (3x). SA matrix at 10 mg/ml
concentration in 50% ACN, 44.8% ultra pure water, 5%
IPA and 0.2% TFA was used. Number of droplets and lay-
ers was variable.
Matrix Deposition – ImagePrep
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The ImagePrep station (Bruker Daltonics) was operated
as per manufacturer’s instructions to deposit homogeneous
matrix layers onto tissue sections. SA at concentrations of
6, 8 and 10 mg/ml in 50% ACN, 5% IPA and 0.2% TFA
were deposited using the default SA ImagePrep method
(Bruker Daltonics). Microscopic slide images were cap-
tured using a Nikon pathology microscope connected to a
digital camera.
MALDI-TOF Imaging Mass Spectrometry and Data
Analysis
Slides for automated MALDI-TOF analysis were scanned
at 1200 dpi using a Powerbook III PrePress Digital colour
scanner (Amersham Biosciences, Soeborg, Denmark) con-
trolled by Magic Scan software (version 4.6, UMAX). Slides
were fitted into a Slide Adapter II MALDI target (Bruker
Daltonics). An Ultra Flex III MALDITOF/ TOF mass spec-
trometer (Bruker Daltonics) operating in linear mode was
used for IMS acquisition. Scanned slide images were loaded
into Flex Imaging software (version 2.0, Bruker Daltonics),
which was used to generate an auto execute sequence and
set teach points for each individual IMS experiment. Ho-
mogeneous matrix layers generated by the ImagePrep were
analysed at a raster suited to the quality of the preparation.
Droplet arrays generated by the CHIP-1000 were analysed
at a raster of the same size as the centre to centre droplet
distance (250 ìm). Auto execute parameters were set by
Flex Control software (version 3.0, Bruker Daltonics) and
a fixed laser power was selected by the operator. Results
from IMS acquisition were observed in Flex Imaging and
Flex Analysis software (version 3.0, Bruker Daltonics).
Results and Discussion
Stability of Imaging Mass Spectrometry Instrumenta-
tion Allows Successful Application
The IMS methodology is rather straightforward in that it
involves use of tissue sections mounted on a conductive
surface, which are washed in alcohol to fix protein and wash
away contaminants, coated in matrix and analysed by
MALDI-TOF MS. Established tissue washes were used
for our applications, including simple washes in 70% EtOH
or IPA and 100% EtOH or IPA (Schwartz, Reyzer et al.
2003; Seeley, Oppenheimer et al. 2008). The difference in
Figure 1: Matrix deposition strategies and resultant crystal formations The two dominant methods of matrix
eposition are droplet deposition in a fixed array (A) and spray deposition to generate a homogeneous crystal coating (B and
C). The matrix array shown in A was generated by a CHIP-1000 piezo electric printer (Shimadzu) with a centre to centre
distance of 250 ìm using 10 mg/ml sinapinic acid (SA) in 50% acetonitrile (ACN), 44.8% ultra pure water, 5% isopropanol
(IPA) and 0.2% trifluoroacetic acid (TFA). One droplet was deposited at each position for each of 25 layers. Droplet arrayed
tissue section was washed in 70% and 100% IPA prior to matrix deposition. The homogeneous matrix layers generated in B
and C were deposited by an ImagePrep station (Bruker Daltonics) using 6 mg/ml (B) or 10 mg/ml (C) SA with identical
solvent compositions to those used for the CHIP-1000. The scale bars in B and C are 30 ìm. ImagePrep tissues   were
washed in 70% and 100% ethanol prior to matrix deposition.
A B
C
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terms of EtOH and IPA is marginal, but as demonstrated
previously, IPA generates slightly better spectral data (Seeley,
Oppenheimer et al. 2008). IMS requires automated matrix
deposition: stability at this stage is critical to ensure repro-
ducibility and prevent protein/peptide delocalisation due to
matrix pooling on the section. The two automated systems,
the Shimadzu CHIP-1000 Piezoelectric printer and the
Bruker Daltonics ImagePrep station, were chosen for their
availability and demonstration of applicability, both in the
literature (Groseclose, Andersson et al. 2007) and in practi-
cal terms. The CHIP-1000 has been utilised for experiments
on Murine brain, as shown in figure 1. The SA matrix crys-
tals in figure 1A were arranged in a 250 ìm centre to centre
array coating the coronal Murine brain section and these
array foci appeared as discrete, dark spots on the section
surface. Printer stability was paramount, as instability leads
to dispensing of droplets in multiple directions, interrupting
the grid pattern, but more importantly, potentially causing
random delocalisation of proteins and peptides. However,
with fine modulation of piezoelectric voltage during printing,
large droplet arrays, as shown in figure 1A, were consis-
tently deposited. Proper printer function was also found to
be dependent on the stability of pressure lines feeding into
the piezo unit and the condition/cleanliness of the external
portions of the print head. These operations were also con-
sidered during fine tuning of the printing process and add to
the complexity of the instrument. Furthermore, the matrix
itself can generate problems in that SA, for example, can
cause significant blockages of the piezo printing orifice at
concentrations above 10 mg/ml. The ImagePrep station,
which generates homogeneous matrix layers, maintains sta-
bility dependent on instrument specific methods, the condi-
tion of the piezo controlled nebulizer membrane as well as
matrix concentration. In a trial of the instrument it was found
that while 6 mg/ml SA can generate a homogeneous field of
discrete matrix crystals, 10 mg/ml SA in an identical solvent
mixture generates larger matrix foci, decreasing the pos-
sible resolution of the homogeneous spray preparation (Fig-
ure 1B and 1C respectively). Matrix blockages caused by
crystallisation of SA on the nebulizer membrane do not have
dramatic effects on spray quality until a significant portion
(>50%) of the membrane surface is covered. Resolution,
while limited in these examples to arrays of 250 ìm or more
using a CHIP-1000 printer (Figure 1A, 2A-D), was reduced
to 70 ìm with the ImagePrep automated spray system (Fig-
ure 2E). Pending further experiments, however, it is un-
clear how comparable the two systems are in terms of re-
producibility.
Imaging the Murine Brain at the Protein Level with
the CHIP-1000 and ImagePrep
Rodent and in particular the Murine brain, was a logical
start point for IMS experiments due to its well character-
ized symmetrical structure and ease of handling once fro-
zen. From a single acquisition point in an IMS experiment
anywhere from 100-400 masses can be observed with typi-
cal array spectra showing high signal to noise (S/N) values
for numerous masses in the range of 5-30 kDa (Chaurand,
Norris et al. 2006). And as shown in figures 2AD, masses
analysed correlate to internal section structure. Similar re-
sults are generated for homogeneous matrix layers, but these
are generally more difficult to reproduce because control
over droplet deposition is lost (data not shown). With proper
modulation of instrument settings for both the CHIP-1000
and ImagePrep station, ion intensity maps resulting from
multiple successful MALDI-TOF tissue acquisitions were
generated as shown in figures 2F and 2G respectively. These
results are key proofs of principle: currently these experi-
ments show potential biological significance, which can be
verified with future experimental determination of mass/pro-
tein identity by LC-MS/MS.
Importantly, it is worth considering that the CHIP-1000
and ImagePrep, as a result of generating different crystal
structures, become well suited to different modes of IMS.
Droplet arrays are suited to low resolution protein profiling:
where different tissue areas are rapidly scanned for identi-
fication of a tissue signature based upon molecular ion de-
terminants (Yanagisawa, Shyr et al. 2003). Homogeneous
matrix layers on the other hand are suited to pure imaging
experiments where high resolution tracking of a defined ion
or initial tissue overview is needed. Figure 2F shows the ion
maps corresponding to three different m/z-s and their spa-
tial distribution across the tissue following acquisition from
a printed droplet array. Compared to the ImagePrep data in
figure 2G, the low resolution seems to be a drawback of the
CHIP-1000 matrix array. While high resolution is obtain-
able with the ImagePrep with a hands free automated sys-
tem, the CHIP-1000 allows rapid deposition of multiple drop-
lets in an array or single point format. Combined with histol-
ogy, the printer systems are extremely well suited to rapid
tissue profiling to provide molecular identification which
complements classical pathology. Furthermore, the MS ac-
quisition time for droplet arrays is far less than the high
resolution spray preparations. A typical array coating a coro-
nal Murine brain section at a raster of 250 ìm (Figure 1A)
takes approximately one hour to analyse by MALDI-
TOFMS, where as a similar experiment using a 70 ìm ras-
ter or lower can take in excess of four hours. This limits
high resolution IMS to the research laboratory until such a
time when MALDI laser frequencies have increased by at
least two fold.
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Figure 2: Imaging the Murine brain utilising automated matrix deposition Figures A-D show single ion intenity
map examples from an imaging mass spectrometry experiment where 10 mg/ml sinapinic acid (SA) in 50% acetonitrile
ACN), 44.8% ultra pure water, 5% isopropanol (IPA) and 0.2% trifluoroacetic acid (TFA) was deposited in 1 droplet
iterations per layer in 25 layers onto a 10 ìm thick section of coronal Murine brain tissue using the CHIP-1000 (all experi-
ments below used identical matrix solvent compositions). Array was 250 ìm centre to centre and can be seen overlaid onto
figures A-D. Tissues in A-D were washed in 70% and 100% IPA prior to matrix deposition. Figure E shows a combination
of three separate ion intensity maps where intensity of the individual colour correlates to relative ion intensity at that
location. A 10 ìm thick sagittal Murine brain section was coated with 10 mg/ml SA using an ImagePrep station. The
instrument was operated with default SA settings and manual determination of spray power. Scale bare in E is 1 mm. Figure
F shows three combined ion intensity maps from an experiment where 10 mg/ml SA was deposited in 24 droplet layers onto
a 10 ìm thick sagittal Murine brain section. Figure G shows a combination of the same three separate ion intensity maps at
a resolution of 100 ìm. This separate 10 ìm thick sagittal Murine brain section was coated with 10 mg/ml SA in identical
solvents to those above using an ImagePrep station. The instrument was operated with default SA settings and manual
determination of spray power. Scale bars for F and G are 2 mm. An Ultra Flex III MALDI-TOF/TOF mass spectrometer
(Bruker Daltonics) was used for acquisition and analysis was performed in Flex Imaging software (version 2.0, Bruker
Daltonics).
Conclusion
IMS technology, although in its infancy compared to es-
tablished proteomic methods, including HPLC and two di-
mensional gels, has shown and continues to show its ex-
treme potential through numerous applications in biological
systems. Our laboratory has set up and begun the process
of evaluating the methodology for performing high quality
IMS experiments using automated systems such as the
CHIP-1000 printer and ImagePrep station for matrix depo-
sition. As a result we have observed that both systems can
be confidently applied to Murine brain tissue for the pur-
pose of imaging, at both rapid medium resolution (CHIP-
1000) and high resolution (ImagePrep).
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